{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:31:25Z","timestamp":1787923885030,"version":"build-2784847793"},"reference-count":256,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006955","name":"Office of Extramural Research","doi-asserted-by":"publisher","award":["NS-131416"],"award-info":[{"award-number":["NS-131416"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research","doi-asserted-by":"publisher","award":["AI-177600"],"award-info":[{"award-number":["AI-177600"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Immunogenicity of CRISPR-associated nucleases (Cas) is a critical barrier to the development of safe and effective genome editing therapies. These proteins inherently pose a risk of immune recognition due to their prokaryotic origins. A multitude of factors, such as the delivery vehicle, the route of administration, components of the therapeutics, tissue microenvironment, and pre-existing immunity, also contribute to the complexity of the host immune response to Cas proteins. As CRISPR-based therapies advance into clinical settings, it is imperative to elucidate and address the immunogenicity of Cas proteins. Here, using Cas9 as an example, we review the current understanding of Cas protein immunogenicity, the challenges it poses for therapeutic application, and strategies to mitigate cellular immune responses to Cas proteins.<\/jats:p>","DOI":"10.3389\/fmed.2026.1930231","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:59:23Z","timestamp":1787921963000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanisms of and mitigating strategies for cellular immune responses to CRISPR-associated nucleases in genome editing therapy"],"prefix":"10.3389","volume":"13","author":[{"given":"Bryan","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Sumanth Reddy","family":"Gutty","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland W.","family":"Herzog","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University","place":["Indianapolis, IN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Molecular Microbiology and Immunology, School of Medicine, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Pathobiology and Integrative Biomedical Sciences, College of Veterinary Medicine, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Chemical and Biomedical Engineering, College of Engineering, University of Missouri","place":["Columbia, MO, United States"]},{"name":"Department of Neurology, School of Medicine, University of Missouri","place":["Columbia, MO, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","article-title":"Nucleotide sequence of the IAP gene, responsible for alkaline phosphatase isozyme conversion in Escherichia Coli, and identification of the gene product.","volume":"169","author":"Ishino","year":"1987","journal-title":"J Bacteriol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","article-title":"Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and Mitochondria.","volume":"36","author":"Mojica","year":"2000","journal-title":"Mol Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","article-title":"Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements.","volume":"60","author":"Mojica","year":"2005","journal-title":"J Mol Evol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"Crispr provides acquired resistance against viruses in prokaryotes.","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science."},{"key":"B5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable Dual-RNA-Guided DNA endonuclease in adaptive bacterial immunity.","volume":"337","author":"Jinek","year":"2012","journal-title":"Science."},{"key":"B6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.","volume":"533","author":"Komor","year":"2016","journal-title":"Nature."},{"key":"B7","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-Replace genome editing without double-strand breaks or donor DNA.","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene Editing for Cep290-Associated retinal degeneration.","volume":"390","author":"Pierce","year":"2024","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"Crispr-Cas9 in vivo gene editing for transthyretin amyloidosis.","volume":"385","author":"Gillmore","year":"2021","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease.","volume":"390","author":"Frangoul","year":"2024","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa2309673","article-title":"Exagamglogene autotemcel for transfusion-dependent beta-thalassemia.","volume":"390","author":"Locatelli","year":"2024","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using Crispr\/Cas systems.","volume":"339","author":"Cong","year":"2013","journal-title":"Science."},{"key":"B13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1469-0691.2004.01042.x","article-title":"Colonisation rates of streptococcus pyogenes and staphylococcus aureus in the oropharynx of a young adult population.","volume":"11","author":"Levy","year":"2005","journal-title":"Clin Microbiol Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans.","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","article-title":"High prevalence of streptococcus pyogenes cas9-reactive T cells within the adult human population.","volume":"25","author":"Wagner","year":"2019","journal-title":"Nat Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2014.02.001","article-title":"Crystal structure of cas9 in complex with guide rna and target DNA.","volume":"156","author":"Nishimasu","year":"2014","journal-title":"Cell."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1017\/S0033583518000070","article-title":"Key role of the rec lobe during Crispr-Cas9 activation by \u2018Sensing\u2019, \u2018Regulating\u2019, and \u2018Locking\u2019 the catalytic HNH domain.","volume":"51","author":"Palermo","year":"2018","journal-title":"Quar Rev Biophys."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41467-017-01496-2","article-title":"Structural insights into DNA cleavage activation of Crispr-Cas9 system.","volume":"8","author":"Huai","year":"2017","journal-title":"Nat Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair.","volume":"18","author":"Chang","year":"2017","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrm1202","article-title":"Mechanism and regulation of human non-homologous DNA end-joining.","volume":"4","author":"Lieber","year":"2003","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.4161\/cc.7.18.6679","article-title":"DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells.","volume":"7","author":"Mao","year":"2008","journal-title":"Cell Cycle."},{"key":"B22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","article-title":"Mechanism of eukaryotic homologous recombination.","volume":"77","author":"San Filippo","year":"2008","journal-title":"Annu Rev Biochem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1038\/s41467-019-09693-x","article-title":"Multifunctional Crispr-Cas9 with engineered immunosilenced human T cell epitopes.","volume":"10","author":"Ferdosi","year":"2019","journal-title":"Nat Commun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41467-024-55522-1","article-title":"Rational engineering of minimally immunogenic nucleases for gene therapy.","volume":"16","author":"Raghavan","year":"2025","journal-title":"Nat Commun."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101506","DOI":"10.1016\/j.omtm.2025.101506","article-title":"Aav2 delivery of the Sacas9 gene results in presentation of an HLA-a*02:01-Restricted T cell epitope potent to induce T cell cytotoxicity.","volume":"33","author":"Najera","year":"2025","journal-title":"Mol Therapy Methods Clin Dev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1038\/s41467-021-25414-9","article-title":"Cas9-Derived peptides presented by MHC class II that elicit proliferation of Cd4(+) T-Cells.","volume":"12","author":"Simhadri","year":"2021","journal-title":"Nat Commun."},{"key":"B27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/s1074-7613(00)80323-4","article-title":"Cd28\/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes.","volume":"5","author":"Lenschow","year":"1996","journal-title":"Immunity."},{"key":"B28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/35105024","article-title":"T-Cell regulation by Cd28 and Ctla-4.","volume":"1","author":"Alegre","year":"2001","journal-title":"Nat Rev Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41577-024-01061-1","article-title":"Cd28 co-stimulation: novel insights and applications in cancer immunotherapy.","volume":"24","author":"Lotze","year":"2024","journal-title":"Nat Rev Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.coi.2010.02.013","article-title":"Inflammatory cytokines as a third signal for T cell activation.","volume":"22","author":"Curtsinger","year":"2010","journal-title":"Curr Opin Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1515\/hsz-2014-0320","article-title":"The transporter associated with antigen processing: a key player in adaptive immunity.","volume":"396","author":"Eggensperger","year":"2015","journal-title":"Biol Chem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.it.2008.06.004","article-title":"MHC Class I assembly: out and about.","volume":"29","author":"Raghavan","year":"2008","journal-title":"Trends Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","article-title":"A guide to antigen processing and presentation.","volume":"22","author":"Pishesha","year":"2022","journal-title":"Nat Rev Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.it.2017.04.002","article-title":"Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo.","volume":"38","author":"Halle","year":"2017","journal-title":"Trends Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6769","DOI":"10.1038\/s41467-021-26830-7","article-title":"Cas9-Specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models.","volume":"12","author":"Hakim","year":"2021","journal-title":"Nat Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.4049\/jimmunol.1501721","article-title":"The length distribution of class I-Restricted T cell epitopes is determined by both peptide supply and mhc allele-specific binding preference.","volume":"196","author":"Trolle","year":"2016","journal-title":"J Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.it.2013.06.002","article-title":"Mechanisms of peptide repertoire selection by Hla-Dm.","volume":"34","author":"Pos","year":"2013","journal-title":"Trends Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/ni1516","article-title":"Recent advances in antigen processing and presentation.","volume":"8","author":"Jensen","year":"2007","journal-title":"Nat Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/358764a0","article-title":"Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-Related molecules and are heterogeneous in size.","volume":"358","author":"Chicz","year":"1992","journal-title":"Nature."},{"key":"B40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/345615a0","article-title":"Invariant chain association with Hla-Dr molecules inhibits immunogenic peptide binding.","volume":"345","author":"Roche","year":"1990","journal-title":"Nature."},{"key":"B41","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jlb.66.2.242","article-title":"Role of Cd8alpha+ and Cd8alpha- dendritic cells in the induction of primary immune responses in vivo.","volume":"66","author":"Maldonado-Lopez","year":"1999","journal-title":"J Leukoc Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1146\/annurev-immunol-030409-101212","article-title":"Differentiation of effector CD4 T cell populations.","volume":"28","author":"Zhu","year":"2010","journal-title":"Annu Rev Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nri.2016.94","article-title":"T follicular helper cells in space-time.","volume":"16","author":"Qi","year":"2016","journal-title":"Nat Rev Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/35100512","article-title":"Cross-Presentation in viral immunity and self-tolerance.","volume":"1","author":"Heath","year":"2001","journal-title":"Nat Rev Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3389\/fimmu.2018.01643","article-title":"Current concepts of antigen cross-presentation.","volume":"9","author":"Embgenbroich","year":"2018","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.7809629","article-title":"A phagosome-to-cytosol pathway for exogenous antigens presented on MHC Class I molecules.","volume":"267","author":"Kovacsovics-Bankowski","year":"1995","journal-title":"Science."},{"key":"B47","doi-asserted-by":"publisher","first-page":"12889","DOI":"10.1073\/pnas.1735556100","article-title":"Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens.","volume":"100","author":"Ackerman","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B48","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.cell.2014.04.054","article-title":"TLR signals induce phagosomal MHC-I delivery from the endosomal recycling compartment to allow cross-presentation.","volume":"158","author":"Nair-Gupta","year":"2014","journal-title":"Cell."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e2005840","DOI":"10.1371\/journal.pbio.2005840","article-title":"In vitro-transcribed guide RNAS trigger an innate immune response via the RIG-I pathway.","volume":"16","author":"Wienert","year":"2018","journal-title":"PLoS Biol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","article-title":"A toll-like receptor recognizes bacterial DNA.","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MYD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice.","volume":"119","author":"Zhu","year":"2009","journal-title":"J Clin Invest."},{"key":"B52","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.1182\/blood-2010-10-314518","article-title":"The genome of self-complementary adeno-associated viral vectors increases toll-like receptor 9-dependent innate immune responses in the liver.","volume":"117","author":"Martino","year":"2011","journal-title":"Blood."},{"key":"B53","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-Like receptors and their crosstalk with other innate receptors in infection and immunity.","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity."},{"key":"B54","doi-asserted-by":"publisher","first-page":"103997","DOI":"10.1016\/j.cellimm.2019.103997","article-title":"Tlr9 signaling mediates adaptive immunity following systemic AAV gene therapy.","volume":"346","author":"Ashley","year":"2019","journal-title":"Cell Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2018.10.080","article-title":"The Sting-Stat6 pathway drives cas9-induced host response in human monocytes.","volume":"506","author":"Kang","year":"2018","journal-title":"Biochem Biophys Res Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1084\/jem.20180139","article-title":"The CGAS-CGAMP-Sting pathway connects DNA damage to inflammation, senescence, and cancer.","volume":"215","author":"Li","year":"2018","journal-title":"J Exp Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"ra20","DOI":"10.1126\/scisignal.2002521","article-title":"Sting specifies irf3 phosphorylation by Tbk1 in the cytosolic DNA signaling pathway.","volume":"5","author":"Tanaka","year":"2012","journal-title":"Sci Signal."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e2100225118","DOI":"10.1073\/pnas.2100225118","article-title":"TBK1 recruitment to sting activates both IRF3 and NF-Kappab that mediate immune defense against tumors and viral infections.","volume":"118","author":"Yum","year":"2021","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1126\/science.1165409","article-title":"Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A.","volume":"322","author":"Sankaran","year":"2008","journal-title":"Science."},{"key":"B60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1749-6632.2010.05574.x","article-title":"Transcriptional silencing of fetal hemoglobin by BCL11A.","volume":"1202","author":"Sankaran","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1001\/2013.jamaophthalmol.354","article-title":"Visual acuity changes in patients with leber congenital amaurosis and mutations in Cep290.","volume":"131","author":"McAnany","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","article-title":"Crispr-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy.","volume":"391","author":"Fontana","year":"2024","journal-title":"N Engl J Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1056\/NEJMoa2309149","article-title":"Crispr-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema.","volume":"390","author":"Longhurst","year":"2024","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1056\/NEJMoa2405734","article-title":"Crispr-Based therapy for hereditary angioedema.","volume":"392","author":"Cohn","year":"2025","journal-title":"N Engl J Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1056\/NEJMoa2510209","article-title":"Nexiguran ziclumeran gene editing in hereditary attr with polyneuropathy.","volume":"393","author":"Gillmore","year":"2025","journal-title":"N Engl J Med."},{"key":"B66","volume-title":"Intelia Therapeutics Provides Update on Magnitude Clinical Trials of Nexiguran Ziclumeran (Nex-Z).","year":"2025"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/10430342251401593","article-title":"Patient dies after treatment with intellia crispr therapy in Phase III trial.","volume":"37","author":"Philippidis","year":"2026","journal-title":"Hum Gene Ther."},{"key":"B68","article-title":"Crispr-Hfcas12max Genome Editing Therapy Demonstrates Preclinical Efficacy and Early Clinical Benefit in Duchenne Muscular Dystrophy.","volume-title":"Proceedings of the 28th Annual Meeting of the American Society of Cell and Gene Therapy.","author":"Luk","year":"2025"},{"key":"B69","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/procel\/pwac052","article-title":"An engineered XCAS12I with high activity, high specificity, and broad pam range.","volume":"14","author":"Zhang","year":"2023","journal-title":"Protein Cell."},{"key":"B70","volume-title":"Once Again, Child Dies in Gene-Editing Trialin China, Rekindling Debate on Transparencyand Safety.","author":"Mast","year":"2026"},{"key":"B71","article-title":"A Clinical Dmd Cytosine Base Editing Drug.","volume-title":"Proceedings of the 28th Annual Meeting of the American Society of Cell and Gene Therapy.","author":"He","year":"2025"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after high-dose Raav9 gene therapy in a patient with duchenne\u2019s muscular dystrophy.","volume":"389","author":"Lek","year":"2023","journal-title":"N Engl J Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1016\/j.ymthe.2025.05.017","article-title":"Lung endothelial transduction in a patient that succumbed to acute respiratory distress syndrome following high-dose Raav9 gene therapy.","volume":"33","author":"Hordeaux","year":"2025","journal-title":"Mol Ther."},{"key":"B74","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/nature07657","article-title":"Complete but curtailed T-Cell response to very low-affinity antigen.","volume":"458","author":"Zehn","year":"2009","journal-title":"Nature."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/biomedicines10061224","article-title":"Antigen load and T cell function: a challenging interaction in HBV infection.","volume":"10","author":"Montali","year":"2022","journal-title":"Biomedicines."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1084\/jem.20060928","article-title":"Duration of the initial TCR stimulus controls the magnitude but not functionality of the Cd8+ T cell response.","volume":"203","author":"Prlic","year":"2006","journal-title":"J Exp Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.1175455","article-title":"Recruitment of antigen-specific Cd8+ T cells in response to infection is markedly efficient.","volume":"325","author":"van Heijst","year":"2009","journal-title":"Science."},{"key":"B78","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/21645515.2018.1527496","article-title":"The effect of antigen dose on T cell-targeting vaccine outcome.","volume":"15","author":"Billeskov","year":"2019","journal-title":"Hum Vaccin Immunother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1172\/JCI16887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J Clin Invest."},{"key":"B80","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","article-title":"The balance between Cde8(+) T cell-mediated clearance of AAV-encoded antigen in the liver and tolerance is dependent on the vector dose.","volume":"25","author":"Kumar","year":"2017","journal-title":"Mol Therapy."},{"key":"B81","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation.","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat Rev Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T Cell exhaustion.","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"Cd8 T cell exhaustion during chronic viral infection and cancer.","volume":"37","author":"McLane","year":"2019","journal-title":"Annu Rev Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/mt.2011.289","article-title":"Retroviral integrations in gene therapy trials.","volume":"20","author":"Biasco","year":"2012","journal-title":"Mol Ther."},{"key":"B85","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-Associated virus vector as a platform for gene therapy delivery.","volume":"18","author":"Wang","year":"2019","journal-title":"Nat Rev Drug Discovery."},{"key":"B86","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class i-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-Deleted recombinant adenoviruses.","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity."},{"key":"B87","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors.","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol Therapy."},{"key":"B88","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform.","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat Nanotechnol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"e70066","DOI":"10.1002\/wnan.70066","article-title":"Advances in engineered virus-like particles for applications in nanomedicine.","volume":"18","author":"Shi","year":"2026","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1189\/jlb.1102574","article-title":"Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation.","volume":"74","author":"Streilein","year":"2003","journal-title":"J Leukoc Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/j.1600-065X.2006.00441.x","article-title":"CNS immune privilege: hiding in plain sight.","volume":"213","author":"Carson","year":"2006","journal-title":"Immunol Rev."},{"key":"B92","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/mi.2008.27","article-title":"Immune privilege or privileged immunity?","volume":"1","author":"Forrester","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1146\/annurev.immunol.021908.132629","article-title":"The liver as a lymphoid organ.","volume":"27","author":"Crispe","year":"2009","journal-title":"Annu Rev Immunol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/nri2858","article-title":"Antigen-Presenting cell function in the tolerogenic liver environment.","volume":"10","author":"Thomson","year":"2010","journal-title":"Nat Rev Immunol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/nri2236","article-title":"Regulation of immunological homeostasis in the respiratory tract.","volume":"8","author":"Holt","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation.","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/eye.2008.382","article-title":"Ocular immune privilege.","volume":"23","author":"Taylor","year":"2009","journal-title":"Eye."},{"key":"B98","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/jleuko\/qiac016","article-title":"Ocular immune privilege and retinal pigment epithelial cells.","volume":"113","author":"Du","year":"2023","journal-title":"J Leukoc Biol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"102446","DOI":"10.1016\/j.arr.2024.102446","article-title":"Senescence-Associated microvascular endothelial dysfunction: a focus on the blood-brain and blood-retinal barriers.","volume":"100","author":"Kim","year":"2024","journal-title":"Ageing Res Rev."},{"key":"B100","doi-asserted-by":"publisher","first-page":"724601","DOI":"10.3389\/fimmu.2021.724601","article-title":"The role of retinal pigment epithelial cells in regulation of macrophages\/microglial cells in retinal immunobiology.","volume":"12","author":"Taylor","year":"2021","journal-title":"Front Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4137\/oed.s2858","article-title":"Anterior chamber-associated immune deviation (ACAID): an acute response to ocular insult protects from future immune-mediated damage?","volume":"1","author":"Cone","year":"2009","journal-title":"Ophthalmol Eye Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3389\/fimmu.2017.01686","article-title":"Cellular and molecular mechanisms of anterior chamber-associated immune deviation (Acaid): what we have learned from knockout mice.","volume":"8","author":"Vendomele","year":"2017","journal-title":"Front Immunol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/jamaophthalmol.2018.6902","article-title":"Immune response and intraocular inflammation in patients with leber hereditary optic neuropathy treated with intravitreal injection of recombinant adeno-associated virus 2 carrying the Nd4 gene: a secondary analysis of a phase 1\/2 clinical trial.","volume":"137","author":"Bouquet","year":"2019","journal-title":"JAMA Ophthalmol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/tvst.10.4.3","article-title":"Inflammation in viral vector-mediated ocular gene therapy: a review and report from a workshop hosted by the foundation fighting blindness, 9\/2020.","volume":"10","author":"Chan","year":"2021","journal-title":"Transl Vis Sci Technol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1038\/s41577-025-01175-0","article-title":"Redefining CNS immune privilege.","volume":"25","author":"Smyth","year":"2025","journal-title":"Nat Rev Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels.","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/mt.2011.33","article-title":"Nonredundant roles of Il-10 and Tgf-Beta in suppression of immune responses to hepatic aav-factor IX gene transfer.","volume":"19","author":"Hoffman","year":"2011","journal-title":"Mol Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"103728","DOI":"10.1016\/j.cellimm.2017.12.002","article-title":"Liver induced transgene tolerance with AAV vectors.","volume":"342","author":"Keeler","year":"2019","journal-title":"Cell Immunol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","article-title":"Liver-Mediated adaptive immune tolerance.","volume":"10","author":"Zheng","year":"2019","journal-title":"Front Immunol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1182\/blood-2004-03-0847","article-title":"Induction of antigen-specific Cd4+ T-Cell anergy and deletion by in vivo viral gene transfer.","volume":"104","author":"Dobrzynski","year":"2004","journal-title":"Blood."},{"key":"B111","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3121\/cmr.3.4.234","article-title":"Tolerance induction by viral in vivo gene transfer.","volume":"3","author":"Dobrzynski","year":"2005","journal-title":"Clin Med Res."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1182\/blood-2007-02-073304","article-title":"Induction and role of regulatory Cd4+Cd25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer.","volume":"110","author":"Cao","year":"2007","journal-title":"Blood."},{"key":"B113","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1538-7836.2009.03417.x","article-title":"Role of regulatory T cells in tolerance to coagulation factors.","volume":"7","author":"Cao","year":"2009","journal-title":"J Thromb Haemost."},{"key":"B114","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1089\/hum.2011.063","article-title":"Immunodominant liver-specific expression suppresses transgene-directed immune responses in murine pompe disease.","volume":"23","author":"Zhang","year":"2012","journal-title":"Hum Gene Ther."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/emmm.201302859","article-title":"Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies.","volume":"5","author":"Markusic","year":"2013","journal-title":"EMBO Mol Med."},{"key":"B116","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3389\/fimmu.2020.00618","article-title":"Translational potential of immune tolerance induction by AAV liver-directed factor viii gene therapy for hemophilia A.","volume":"11","author":"Samelson-Jones","year":"2020","journal-title":"Front Immunol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ymthe.2024.03.016","article-title":"Immune tolerance induction by hepatic gene transfer: first-in-human evidence.","volume":"32","author":"Kaczmarek","year":"2024","journal-title":"Mol Ther."},{"key":"B118","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1089\/hum.2008.161","article-title":"Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transfer.","volume":"20","author":"Cooper","year":"2009","journal-title":"Hum Gene Ther."},{"key":"B119","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ymthe.2023.11.029","article-title":"Tlr9-Independent Cd8(+) T cell responses in hepatic AAV gene transfer through Il-1r1-Myd88 signaling.","volume":"32","author":"Kumar","year":"2024","journal-title":"Mol Ther."},{"key":"B120","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/1566523215666150630121750","article-title":"The skeletal muscle environment and its role in immunity and tolerance to AAV vector-mediated gene transfer.","volume":"15","author":"Boisgerault","year":"2015","journal-title":"Curr Gene Ther."},{"key":"B121","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/cdd.2015.171","article-title":"Cell death, clearance and immunity in the skeletal muscle.","volume":"23","author":"Sciorati","year":"2016","journal-title":"Cell Death Differ."},{"key":"B122","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nri3600","article-title":"Alveolar macrophages: plasticity in a tissue-specific context.","volume":"14","author":"Hussell","year":"2014","journal-title":"Nat Rev Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1136\/thoraxjnl-2015-207020","article-title":"Pulmonary macrophages: key players in the innate defence of the airways.","volume":"70","author":"Byrne","year":"2015","journal-title":"Thorax."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3390\/biomedicines9101447","article-title":"The immune system in duchenne muscular dystrophy pathogenesis.","volume":"9","author":"Tripodi","year":"2021","journal-title":"Biomedicines."},{"key":"B125","doi-asserted-by":"publisher","first-page":"540370","DOI":"10.1155\/2013\/540370","article-title":"Cytokines and chemokines as regulators of skeletal muscle inflammation: presenting the case of duchenne muscular dystrophy.","volume":"2013","author":"De Paepe","year":"2013","journal-title":"Med Inflamm."},{"key":"B126","volume-title":"Compositions and Methods for Improved Nucleases.","author":"Cavallo","year":"2019"},{"key":"B127","article-title":"Molecular therapy.","volume-title":"This is a Conference Presentation at 26th Annual Meeting of the American Society of Gene &amp; Cell Therapy","author":"Nitsch","year":"2023"},{"key":"B128","doi-asserted-by":"publisher","first-page":"295","DOI":"10.4161\/auto.4144","article-title":"Chaperone-Mediated autophagy.","volume":"3","author":"Dice","year":"2007","journal-title":"Autophagy."},{"key":"B129","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrm3150","article-title":"Chaperone-Mediated autophagy: dice\u2019s \u2018Wild\u2019 idea about lysosomal selectivity.","volume":"12","author":"Cuervo","year":"2011","journal-title":"Nat Rev Mol Cell Biol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1242\/jcs.073874","article-title":"Chaperone-Mediated autophagy at a glance.","volume":"124","author":"Kaushik","year":"2011","journal-title":"J Cell Sci."},{"key":"B131","doi-asserted-by":"publisher","first-page":"5414","DOI":"10.1074\/jbc.R117.818237","article-title":"Chaperone-Mediated autophagy and endosomal microautophagy: joint by a chaperone.","volume":"293","author":"Tekirdag","year":"2018","journal-title":"J Biol Chem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/375685a0","article-title":"Inhibition of antigen processing by the internal repeat region of the epstein-barr virus nuclear Antigen-1.","volume":"375","author":"Levitskaya","year":"1995","journal-title":"Nature."},{"key":"B133","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","article-title":"Inhibition of Ubiquitin\/Proteasome-Dependent protein degradation by the Gly-Ala repeat domain of the epstein-barr virus nuclear antigen 1.","volume":"94","author":"Levitskaya","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B134","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1074\/jbc.M310449200","article-title":"Repeat sequence of epstein-barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing.","volume":"279","author":"Zhang","year":"2004","journal-title":"J Biol Chem."},{"key":"B135","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/sj.emboj.7601058","article-title":"Glycine-Alanine repeats impair proper substrate unfolding by the proteasome.","volume":"25","author":"Hoyt","year":"2006","journal-title":"EMBO J."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.1088902","article-title":"Self-Inhibition of synthesis and antigen presentation by epstein-barr virus-encoded ebna1.","volume":"301","author":"Yin","year":"2003","journal-title":"Science."},{"key":"B137","doi-asserted-by":"publisher","first-page":"gkaf586","DOI":"10.1093\/nar\/gkaf586","article-title":"The epstein-barr virus ebna1 protein binds to G-quadruplexes in its own mrna hence controlling its expression and immune evasion of the virus.","volume":"53","author":"Dinh","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/gt.2014.22","article-title":"Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve.","volume":"21","author":"Hoyng","year":"2014","journal-title":"Gene Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/brain\/awy340","article-title":"Timed GDNF gene therapy using an immune-evasive gene switch promotes long distance axon regeneration.","volume":"142","author":"Eggers","year":"2019","journal-title":"Brain."},{"key":"B140","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrg2628","article-title":"Exploiting and antagonizing microrna regulation for therapeutic and experimental applications.","volume":"10","author":"Brown","year":"2009","journal-title":"Nat Rev Genet."},{"key":"B141","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells13010084","article-title":"Mir-142: a master regulator in hematological malignancies and therapeutic opportunities.","volume":"13","author":"Huang","year":"2023","journal-title":"Cells."},{"key":"B142","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/jgm.2712","article-title":"Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated Virus 1 vector-mediated gene delivery.","volume":"15","author":"Majowicz","year":"2013","journal-title":"J Gene Med."},{"key":"B143","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/hum.2012.208","article-title":"Prolonged gene expression in muscle is achieved without active immune tolerance using microrrna 142.3p-Regulated RAAV gene transfer.","volume":"24","author":"Boisgerault","year":"2013","journal-title":"Hum Gene Ther."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e99052","DOI":"10.1172\/jci.insight.99052","article-title":"Circumventing cellular immunity by Mir142-Mediated regulation sufficiently supports RAAV-Delivered ova expression without activating humoral immunity.","volume":"4","author":"Xiao","year":"2019","journal-title":"JCI Insight."},{"key":"B145","doi-asserted-by":"publisher","first-page":"674242","DOI":"10.3389\/fimmu.2021.674242","article-title":"Novel combinatorial microrna-binding sites in AAV vectors synergistically diminish antigen presentation and transgene immunity for efficient and stable transduction.","volume":"12","author":"Muhuri","year":"2021","journal-title":"Front Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000369273","article-title":"Unique roles of Tlr9- and Myd88-Dependent and -independent pathways in adaptive immune responses to AAV-Mediated gene transfer.","volume":"7","author":"Rogers","year":"2015","journal-title":"J Innate Immun."},{"key":"B147","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1182\/blood-2016-11-751040","article-title":"Plasmacytoid and conventional dendritic cells cooperate in crosspriming AAV Capsid-Specific Cd8(+) T Cells.","volume":"129","author":"Rogers","year":"2017","journal-title":"Blood."},{"key":"B148","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1172\/JCI68205","article-title":"CPG-Depleted adeno-associated virus vectors evade immune detection.","volume":"123","author":"Faust","year":"2013","journal-title":"J Clin Invest."},{"key":"B149","doi-asserted-by":"publisher","first-page":"672449","DOI":"10.3389\/fimmu.2021.672449","article-title":"Effect of CPG depletion of vector genome on Cd8(+) T cell responses in AAV gene therapy.","volume":"12","author":"Bertolini","year":"2021","journal-title":"Front Immunol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41434-021-00296-0","article-title":"Rational engineering of a functional CPG-Free ITR for AAV gene therapy.","volume":"29","author":"Pan","year":"2022","journal-title":"Gene Therapy."},{"key":"B151","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.4049\/jimmunol.171.3.1393","article-title":"Repetitive elements in mammalian telomeres suppress bacterial DNA-Induced immune activation.","volume":"171","author":"Gursel","year":"2003","journal-title":"J Immunol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1749-6632.2009.04970.x","article-title":"Therapeutic applications and mechanisms underlying the activity of immunosuppressive oligonucleotides.","volume":"1175","author":"Klinman","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"B153","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nature14138","article-title":"Structural basis of CPG and inhibitory DNA recognition by toll-like receptor 9.","volume":"520","author":"Ohto","year":"2015","journal-title":"Nature."},{"key":"B154","doi-asserted-by":"publisher","first-page":"eabd3438","DOI":"10.1126\/scitranslmed.abd3438","article-title":"Engineering adeno-associated viral vectors to evade innate immune and inflammatory responses.","volume":"13","author":"Chan","year":"2021","journal-title":"Sci Transl Med."},{"key":"B155","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1165\/rcmb.2024-0247OC","article-title":"Novel immune response evasion strategy to redose adeno-associated viral vectors and prolong survival in surfactant protein-B-Deficient mice.","volume":"73","author":"Kang","year":"2025","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/v16101507","article-title":"Redundancy in innate immune pathways that promote Cd8(+) T-Cell responses in Aav1 muscle gene transfer.","volume":"16","author":"Li","year":"2024","journal-title":"Viruses."},{"key":"B157","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1371\/journal.pgen.0020221","article-title":"Tissue-Specific differences in human transfer RNA expression.","volume":"2","author":"Dittmar","year":"2006","journal-title":"PLoS Genet."},{"key":"B158","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/nar\/gkq009","article-title":"Translation efficiency in humans: tissue specificity, global optimization and differences between developmental stages.","volume":"38","author":"Waldman","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B159","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1073\/pnas.0909910107","article-title":"Translation efficiency is determined by both codon bias and folding energy.","volume":"107","author":"Tuller","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B160","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s1074-7613(00)80461-6","article-title":"The duration of antigenic stimulation determines the fate of naive and effector T Cells.","volume":"8","author":"Iezzi","year":"1998","journal-title":"Immunity."},{"key":"B161","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1084\/jem.20020158","article-title":"The proliferative capacity of individual naive Cd4(+) T cells is amplified by prolonged T cell antigen receptor triggering.","volume":"196","author":"Schrum","year":"2002","journal-title":"J Exp Med."},{"key":"B162","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni912","article-title":"Dynamic programming of Cd8+ T lymphocyte responses.","volume":"4","author":"van Stipdonk","year":"2003","journal-title":"Nat Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/eji.200635929","article-title":"Duration of CTL activation regulates Il-2 production required for autonomous clonal expansion.","volume":"36","author":"Spierings","year":"2006","journal-title":"Eur J Immunol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jconrel.2022.08.042","article-title":"Lnp-Mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.","volume":"350","author":"Mirjalili Mohanna","year":"2022","journal-title":"J Control Release."},{"key":"B165","doi-asserted-by":"publisher","first-page":"114207","DOI":"10.1016\/j.ejpb.2024.114207","article-title":"Comparative analysis of lipid nanoparticle-mediated delivery of Crispr-Cas9 RNP Versus MRNA\/SGRNA for gene editing in vitro and in vivo.","volume":"196","author":"Walther","year":"2024","journal-title":"Eur J Pharm Biopharm."},{"key":"B166","doi-asserted-by":"publisher","first-page":"13790","DOI":"10.1021\/acsnano.4c16617","article-title":"Lipid nanoparticles for in vivo lung delivery of CRISPR-CAS9 ribonucleoproteins allow gene editing of clinical targets.","volume":"19","author":"Haley","year":"2025","journal-title":"ACS Nano."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/s41587-024-02437-3","article-title":"Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-CAS9 ribonucleoprotein.","volume":"43","author":"Chen","year":"2025","journal-title":"Nat Biotechnol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"e2413519121","DOI":"10.1073\/pnas.2413519121","article-title":"Mechanism-Guided engineering of a minimal biological particle for genome editing.","volume":"122","author":"Ngo","year":"2025","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human t cell engineering with enveloped delivery vehicles.","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat Biotechnol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-026-10235-x","article-title":"In vivo site-specific engineering to reprogram T cells.","volume":"652","author":"Nyberg","year":"2026","journal-title":"Nature."},{"key":"B171","doi-asserted-by":"publisher","first-page":"11911","DOI":"10.1093\/nar\/gkae819","article-title":"Amphiphilic shuttle peptide delivers base editor ribonucleoprotein to correct the CFTR R553x mutation in well-differentiated airway epithelial cells.","volume":"52","author":"Kulhankova","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B172","doi-asserted-by":"publisher","first-page":"113854","DOI":"10.1016\/j.jconrel.2025.113854","article-title":"Lipopeptide-Mediated delivery of Crispr\/Cas9 ribonucleoprotein complexes for gene editing and correction.","volume":"383","author":"Oktem","year":"2025","journal-title":"J Control Release."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.csbj.2019.07.015","article-title":"Drug inducible Crispr\/Cas systems.","volume":"17","author":"Zhang","year":"2019","journal-title":"Comput Struct Biotechnol J."},{"key":"B174","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ymthe.2021.06.014","article-title":"Controlling CRISPR with small molecule regulation for somatic cell genome editing.","volume":"30","author":"Khajanchi","year":"2021","journal-title":"Mol Ther."},{"key":"B175","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/sj.gt.3302780","article-title":"Optimization of the tet-on system for regulated gene expression through viral evolution.","volume":"13","author":"Zhou","year":"2006","journal-title":"Gene Ther."},{"key":"B177","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1472-6750-10-81","article-title":"Improved tet-responsive promoters with minimized background expression.","volume":"10","author":"Loew","year":"2010","journal-title":"BMC Biotechnol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"4903","DOI":"10.1038\/s41467-020-18548-9","article-title":"Development of an obligare doxycycline inducible CAS9 system for pre-clinical cancer drug discovery.","volume":"11","author":"Lundin","year":"2020","journal-title":"Nat Commun."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/jexbot\/51.351.1647","article-title":"Increased leakiness of the tetracycline-inducible Triple-Op promoter in dividing cells renders it unsuitable for high inducible levels of a dominant negative Cdc2aat gene.","volume":"51","author":"De Veylder","year":"2000","journal-title":"J Exp Bot."},{"key":"B180","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2144\/000112896","article-title":"Attenuation of leakiness in doxycycline-inducible expression via incorporation of 3\u2019 Au-Rich MRNA destabilizing elements.","volume":"45","author":"Pham","year":"2008","journal-title":"Biotechniques."},{"key":"B181","doi-asserted-by":"publisher","first-page":"27697","DOI":"10.1038\/srep27697","article-title":"Improvement of the reverse tetracycline transactivator by single amino acid substitutions that reduce leaky target gene expression to undetectable levels.","volume":"6","author":"Roney","year":"2016","journal-title":"Sci Rep."},{"key":"B182","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.2224","article-title":"Multidimensional chemical control of Crispr-Cas9.","volume":"13","author":"Maji","year":"2017","journal-title":"Nat Chem Biol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1126\/science.adp8179","article-title":"Ribozyme-Activated MRNA trans-ligation enables large gene delivery to treat muscular dystrophies.","volume":"386","author":"Lindley","year":"2024","journal-title":"Science."},{"key":"B184","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41467-025-67201-w","article-title":"Chemically-Inducible Crispr\/Cas9 circuits for ultra-high dynamic range gene perturbation.","volume":"17","author":"Srinivasan","year":"2025","journal-title":"Nat Commun."},{"key":"B185","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/nrg2172","article-title":"Ribozymes, riboswitches and beyond: regulation of gene expression without proteins.","volume":"8","author":"Serganov","year":"2007","journal-title":"Nat Rev Genet."},{"key":"B186","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.febslet.2012.02.038","article-title":"Engineered riboswitches: expanding researchers\u2019 toolbox with synthetic RNA regulators.","volume":"586","author":"Wittmann","year":"2012","journal-title":"FEBS Lett."},{"key":"B187","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41587-019-0357-y","article-title":"A reversible RNA on-Switch that controls gene expression of AAV-delivered therapeutics in vivo.","volume":"38","author":"Zhong","year":"2020","journal-title":"Nat Biotechnol."},{"key":"B188","article-title":"A Programmable Rna Switch Platform Enables Ultra-Tight Regulation of Gene Therapies.","volume-title":"Proceedings of the 29th Annual Meeting of the American Society of Cell and Gene Therapy.","author":"Du","year":"2026"},{"key":"B189","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","article-title":"The self-inactivating Kamicas9 system for the editing of CNS disease genes.","volume":"20","author":"Merienne","year":"2017","journal-title":"Cell Rep."},{"key":"B190","doi-asserted-by":"publisher","first-page":"15334","DOI":"10.1038\/ncomms15334","article-title":"Hit and go Cas9 delivered through a lentiviral based self-limiting circuit.","volume":"8","author":"Petris","year":"2017","journal-title":"Nat Commun."},{"key":"B191","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","article-title":"A self-deleting AAV-CRISPR system for in vivo genome editing.","volume":"12","author":"Li","year":"2019","journal-title":"Mol Therapy Methods Clin Dev."},{"key":"B192","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ymthe.2019.09.006","article-title":"Doxycycline-Dependent self-inactivation of Crispr-Cas9 to temporally regulate on- and off-target editing.","volume":"28","author":"Kelkar","year":"2020","journal-title":"Mol Ther."},{"key":"B193","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.omtm.2020.06.012","article-title":"Development of a self-restricting crispr-cas9 system to reduce off-target effects.","volume":"18","author":"Wang","year":"2020","journal-title":"Mol Therapy Methods Clin Dev."},{"key":"B194","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1038\/s41467-021-26518-y","article-title":"Self-Inactivating, all-in-one aav vectors for precision Cas9 genome editing via homology-directed repair in vivo.","volume":"12","author":"Ibraheim","year":"2021","journal-title":"Nat Commun."},{"key":"B195","doi-asserted-by":"publisher","first-page":"e0203921","DOI":"10.1128\/JVI.02039-21","article-title":"Epigenetic Silencing of recombinant adeno-associated virus genomes by Np220 and the hush complex.","volume":"96","author":"Das","year":"2022","journal-title":"J Virol."},{"key":"B196","doi-asserted-by":"publisher","first-page":"113902","DOI":"10.1016\/j.celrep.2024.113902","article-title":"Capsid-Mediated control of adeno-associated viral transcription determines host range.","volume":"43","author":"Loeb","year":"2024","journal-title":"Cell Rep."},{"key":"B197","doi-asserted-by":"publisher","first-page":"eadn0689","DOI":"10.1126\/scitranslmed.adn0689","article-title":"Targeted genome editing restores auditory function in adult mice with progressive hearing loss caused by a human microrna mutation.","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci Transl Med."},{"key":"B198","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41434-025-00589-8","article-title":"Metadata assessment of non-human primate studies of Aav9 uncovers potential tissue specific variation in expression efficiency.","volume":"33","author":"Shahrukh","year":"2026","journal-title":"Gene Ther."},{"key":"B199","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1515\/bchm3.1996.377.3.195","article-title":"Inactivation of the very strong hcmv immediate early promoter by DNA Cpg methylation in vitro.","volume":"377","author":"Prosch","year":"1996","journal-title":"Biol Chem Hoppe Seyler."},{"key":"B200","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/sj.gt.3301221","article-title":"Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.","volume":"7","author":"Paterna","year":"2000","journal-title":"Gene Ther."},{"key":"B201","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/jgm.516","article-title":"Transcriptional silencing is associated with extensive methylation of the CMV promoter following adenoviral gene delivery to muscle.","volume":"6","author":"Brooks","year":"2004","journal-title":"J Gene Med."},{"key":"B202","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.gene.2008.09.033","article-title":"Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.","volume":"428","author":"Mehta","year":"2009","journal-title":"Gene."},{"key":"B203","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41579-020-0382-3","article-title":"Epigenetic and epitranscriptomic regulation of viral replication.","volume":"18","author":"Tsai","year":"2020","journal-title":"Nat Rev Microbiol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1128\/jvi.00493-16","article-title":"Mutants at the 2-Fold interface of adeno-associated virus Type 2 (Aav2) structural proteins suggest a role in viral transcription for AAV capsids.","volume":"90","author":"Aydemir","year":"2016","journal-title":"J Virol."},{"key":"B205","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1038\/s41467-023-38106-3","article-title":"The AAV capsid can influence the epigenetic marking of raav delivered episomal genomes in a species dependent manner.","volume":"14","author":"Gonzalez-Sandoval","year":"2023","journal-title":"Nat Commun."},{"key":"B206","doi-asserted-by":"publisher","first-page":"658038","DOI":"10.3389\/fimmu.2021.658038","article-title":"Immunomodulation in administration of raav: preclinical and clinical adjuvant pharmacotherapies.","volume":"12","author":"Chu","year":"2021","journal-title":"Front Immunol."},{"key":"B207","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1016\/j.ymthe.2024.07.016","article-title":"A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders.","volume":"32","author":"Vrellaku","year":"2024","journal-title":"Mol Ther."},{"key":"B208","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights.","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol."},{"key":"B209","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.3389\/fimmu.2019.01744","article-title":"Glucocorticoids-All-Rounders tackling the versatile players of the immune system.","volume":"10","author":"Strehl","year":"2019","journal-title":"Front Immunol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.coph.2020.03.003","article-title":"Anti-Inflammatory glucocorticoid action: genomic insights and emerging concepts.","volume":"53","author":"Syed","year":"2020","journal-title":"Curr Opin Pharmacol."},{"key":"B211","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-Genomic effects of glucocorticoids: an updated view.","volume":"40","author":"Panettieri","year":"2019","journal-title":"Trends Pharmacol Sci."},{"key":"B212","doi-asserted-by":"publisher","first-page":"s2","DOI":"10.1191\/0961203305lu2109oa","article-title":"Mechanisms of action of mycophenolate mofetil.","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus."},{"key":"B213","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1006\/clin.1996.0140","article-title":"The mechanism of action of cyclosporin a and Fk506.","volume":"80","author":"Ho","year":"1996","journal-title":"Clin Immunol Immunopathol."},{"key":"B214","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1016\/s0041-1345(03)00211-2","article-title":"Sirolimus: its discovery, biological properties, and mechanism of action.","volume":"35","author":"Sehgal","year":"2003","journal-title":"Transplant Proc."},{"key":"B215","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12035-025-05549-2","article-title":"Calcineurin inhibitors: current role, toxicity management, and future frontiers in immunosuppression.","volume":"63","author":"Mistry","year":"2025","journal-title":"Mol Neurobiol."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3389\/fimmu.2017.01245","article-title":"Therapeutic antibodies: what have we learnt from targeting Cd20 and where are we going?","volume":"8","author":"Marshall","year":"2017","journal-title":"Front Immunol."},{"key":"B217","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/mt.2012.84","article-title":"Pharmacological modulation of humoral immunity in a nonhuman primate model of AAV gene transfer for hemophilia B.","volume":"20","author":"Mingozzi","year":"2012","journal-title":"Mol Ther."},{"key":"B218","doi-asserted-by":"publisher","first-page":"101216","DOI":"10.1016\/j.omtm.2024.101216","article-title":"B cell focused transient immune suppression protocol for efficient AAV readministration to the liver.","volume":"32","author":"Rana","year":"2024","journal-title":"Mol Therapy Methods Clin Dev."},{"key":"B219","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-Generation regulatory T cell therapy.","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discov."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1675114","DOI":"10.3389\/fimmu.2025.1675114","article-title":"Regulatory T cell therapies: from patient data to biological insights.","volume":"16","author":"Rodrigues","year":"2025","journal-title":"Front Immunol."},{"key":"B221","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease.","volume":"24","author":"Wardell","year":"2025","journal-title":"Nat Rev Drug Discov."},{"key":"B222","doi-asserted-by":"publisher","first-page":"1762753","DOI":"10.3389\/fimmu.2026.1762753","article-title":"Regulatory T cells in the era of cell and gene therapy: biology, clinical translation, and future prospects.","volume":"17","author":"Sato","year":"2026","journal-title":"Front Immunol."},{"key":"B223","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2025.11.035","article-title":"Next steps in regulatory T cells: biology and clinical application.","volume":"189","author":"Zou","year":"2026","journal-title":"Cell."},{"key":"B224","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance.","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell."},{"key":"B225","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work.","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B226","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fimmu.2012.00051","article-title":"Molecular mechanisms of treg-mediated T cell suppression.","volume":"3","author":"Schmidt","year":"2012","journal-title":"Front Immunol."},{"key":"B227","doi-asserted-by":"publisher","first-page":"304s18","DOI":"10.1126\/scitranslmed.aaa7721","article-title":"Hurdles in therapy with regulatory T cells.","volume":"7","author":"Trzonkowski","year":"2015","journal-title":"Sci Transl Med."},{"key":"B228","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(Reg) cell-based therapies: challenges and perspectives.","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B229","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"Car-T regulatory (Car-Treg) cells: engineering and applications.","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines."},{"key":"B230","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.omtm.2021.10.010","article-title":"Modulating immune responses to aav by expanded polyclonal T-Regs and capsid specific chimeric antigen receptor T-Regulatory cells.","volume":"23","author":"Arjomandnejad","year":"2021","journal-title":"Mol Therapy Methods Clin Dev."},{"key":"B231","doi-asserted-by":"publisher","first-page":"eaba5264","DOI":"10.1126\/sciimmunol.aba5264","article-title":"An Il-2 mutein engineered to promote expansion of regulatory T Cells arrests ongoing autoimmunity in mice.","volume":"5","author":"Khoryati","year":"2020","journal-title":"Sci Immunol."},{"key":"B232","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s43856-024-00485-z","article-title":"A Cd25-Biased Interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism.","volume":"4","author":"Ptacin","year":"2024","journal-title":"Commun Med."},{"key":"B233","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2147\/ITT.S500229","article-title":"Cytokine couture: designer Il2 molecules for the treatment of disease.","volume":"14","author":"Dashwood","year":"2025","journal-title":"Immunotargets Ther."},{"key":"B234","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.it.2015.10.003","article-title":"Interleukin-2: biology, design and application.","volume":"36","author":"Arenas-Ramirez","year":"2015","journal-title":"Trends Immunol."},{"key":"B235","doi-asserted-by":"publisher","first-page":"e20191247","DOI":"10.1084\/jem.20191247","article-title":"Effects of Interleukin-2 in immunostimulation and immunosuppression.","volume":"217","author":"Pol","year":"2020","journal-title":"J Exp Med."},{"key":"B236","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2217\/imt.14.84","article-title":"MTOR signaling, TREGS and immune modulation.","volume":"6","author":"Chapman","year":"2014","journal-title":"Immunotherapy."},{"key":"B237","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.immuni.2025.06.010","article-title":"More TOR: the expanding role of mtor in regulating immune responses.","volume":"58","author":"Patel","year":"2025","journal-title":"Immunity."},{"key":"B238","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jaut.2007.12.012","article-title":"Combination of RAPAMYCIN and Il-2 increases de novo induction of human Cd4(+)Cd25(+)Foxp3(+) T Cells.","volume":"30","author":"Long","year":"2008","journal-title":"J Autoimmun."},{"key":"B239","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on Cd4+Cd25+Foxp3+ regulatory T cells compared with conventional Cd4+ T cells.","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood."},{"key":"B240","doi-asserted-by":"publisher","first-page":"989434","DOI":"10.1155\/2014\/989434","article-title":"Rapamycin regulates itreg function through Cd39 and Runx1 pathways.","volume":"2014","author":"Lu","year":"2014","journal-title":"J Immunol Res."},{"key":"B241","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/j.1538-7836.2009.03548.x","article-title":"Prophylactic immune tolerance induced by changing the ratio of antigen-specific effector to regulatory T cells.","volume":"7","author":"Nayak","year":"2009","journal-title":"J Thromb Haemost."},{"key":"B242","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1707","article-title":"Central tolerance: learning self-control in the thymus.","volume":"5","author":"Hogquist","year":"2005","journal-title":"Nat Rev Immunol."},{"key":"B243","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/ni.1817","article-title":"Mechanisms maintaining peripheral tolerance.","volume":"11","author":"Mueller","year":"2010","journal-title":"Nat Immunol."},{"key":"B244","doi-asserted-by":"publisher","first-page":"a006957","DOI":"10.1101\/cshperspect.a006957","article-title":"T-Cell tolerance: central and peripheral.","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"B245","doi-asserted-by":"publisher","first-page":"28853","DOI":"10.1038\/s41598-024-75698-2","article-title":"AAV-Mediated co-expression of an immunogenic transgene plus PD-L1 enables sustained expression through immunological evasion.","volume":"14","author":"McMurphy","year":"2024","journal-title":"Sci Rep."},{"key":"B246","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41590-020-0620-x","article-title":"Pd-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer.","volume":"21","author":"Diskin","year":"2020","journal-title":"Nat Immunol."},{"key":"B247","doi-asserted-by":"publisher","first-page":"eaay4458","DOI":"10.1126\/sciadv.aay4458","article-title":"Molecular mechanism of Shp2 activation by Pd-1 stimulation.","volume":"6","author":"Marasco","year":"2020","journal-title":"Sci Adv."},{"key":"B248","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/156652309787909490","article-title":"Hepatic gene transfer as a means of tolerance induction to transgene products.","volume":"9","author":"LoDuca","year":"2009","journal-title":"Curr Gene Ther."},{"key":"B249","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape.","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu Rev Virol."},{"key":"B250","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.immuni.2006.03.001","article-title":"CTLA4IG: bridging the basic immunology with clinical application.","volume":"24","author":"Bluestone","year":"2006","journal-title":"Immunity."},{"key":"B251","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/j.1600-065X.2009.00780.x","article-title":"The clinical utility of inhibiting CD28-mediated costimulation.","volume":"229","author":"Linsley","year":"2009","journal-title":"Immunol Rev."},{"key":"B252","doi-asserted-by":"publisher","first-page":"6586","DOI":"10.1073\/pnas.90.14.6586","article-title":"Human T-Cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.","volume":"90","author":"Gimmi","year":"1993","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B253","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.ymthe.2026.04.014","article-title":"Transient prophylactic immunosuppression with Abatacept or DASATINIB prevents immune responses in AAV gene transfer.","volume":"34","author":"Xicluna","year":"2026","journal-title":"Mol Ther."},{"key":"B254","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/CDLI.11.4.635-641.2004","article-title":"Targeting CD40L: a promising therapeutic approach.","volume":"11","author":"Daoussis","year":"2004","journal-title":"Clin Diagn Lab Immunol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1097\/TP.0000000000004469","article-title":"CD40-CD40L blockade: update on novel investigational therapeutics for transplantation.","volume":"107","author":"Singh","year":"2023","journal-title":"Transplantation."},{"key":"B256","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/hum.2023.057","article-title":"Progress in bioengineering of myotropic adeno-associated viral (AAV) gene therapy vectors.","volume":"34","author":"Liu","year":"2023","journal-title":"Hum Gene Ther."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930231\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:59:27Z","timestamp":1787921967000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1930231\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":256,"alternative-id":["10.3389\/fmed.2026.1930231"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1930231","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"article-number":"1930231"}}